The Food and Drug Administration is a government agency that regulates certain food, drugs, cosmetics, and medical products. They are the government agency responsible for reviewing, approving and regulating medical products, including pharmaceutical drugs and medical devices.
-
Cancer care has been transformed by comprehensive molecular profiling and targeted therapies—but with improvements in sample analysis technologies, the volume of information and burden...
OCT 15, 2025 | 9:00 AM
C.E. CREDITS
Despite remarkable success in relapsed or refractory B-cell malignancies, CAR T-cell therapy faces significant challenges: primary resistance, relapse, and treatment-related toxicities. This...
The release of a recent EMA reflection paper, aligning with FDA and WHO positions, has resulted in a renewed focus on the central role of pharmacokinetic (PK) data, the primary status of ana...
JUL 16, 2025 | 3:00 PM
C.E. CREDITS
Digital pathology has a crucial role in diagnostic pathology and is increasingly a technological requirement in the field. Integration of digital slides into the pathology workflow, advanced...
Explore how super-resolution microscopy reveals GPCR and RTK receptor dimerization, with a focus on D2 dopamine receptor function and disease relevance....
APR 03, 2025 | 8:00 AM
C.E. CREDITS
The FDA’s landmark final rule on Laboratory Developed Tests (LDTs) is set to transform the regulatory landscape for diagnostic laboratories. This webinar will provide biomedical diagno...
Join us for an enlightening webinar with Dr. Bruno Paiva, where we will delve into the Next Generation Flow ™ technology. This technology, known for its high sensitivity and standardiz...
JAN 29, 2025 | 12:00 PM
C.E. CREDITS
To provide a discussion space where three experts discuss the FDA LDT ruling and its implications for their lab practices and patient impact practices Allow for an audience-driven discussion...
Antibody-drug conjugates (ADCs) represent the most successful class of active targeting drug-delivery systems, however, despite the increasing number of FDA approvals treatment-related adver...
Each year, more than 134 million patients experience adverse drug events, causing 2.4 million deaths worldwide. What if there was a better way to develop and prescribe safer, more effective...
Liquid biopsy next-generation sequencing (NGS) assays help guide treatment selection in cancer patients, particularly when tumor tissue is unavailable or during disease progression. Extensiv...
Gene therapy has experienced an increasing number of successful human clinical trials, leading to 6 FDA approved products using delivery vectors based on adeno-associated viruses (AAV). Thes...
OCT 16, 2024 | 12:00 PM
C.E. CREDITS
Cell and gene therapy is at the forefront of medical innovation, offering transformative potential for treating complex diseases. However, achieving success in these therapies requires metic...